TTNP - Titan Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
5.18M
Enterprise Value 3
7.32M
Trailing P/E
N/A
Forward P/E 1
-0.46
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
1.20
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
1.69
Enterprise Value/EBITDA 6
-0.52

Trading Information

Stock Price History

Beta (3Y Monthly) 1.03
52-Week Change 3-69.93%
S&P500 52-Week Change 37.98%
52 Week High 33.7800
52 Week Low 30.2400
50-Day Moving Average 30.3742
200-Day Moving Average 31.0941

Share Statistics

Avg Vol (3 month) 3697.46k
Avg Vol (10 day) 33.96M
Shares Outstanding 515.74M
Float 13.92M
% Held by Insiders 14.32%
% Held by Institutions 14.99%
Shares Short (Sep 30, 2019) 41.62M
Short Ratio (Sep 30, 2019) 42.63
Short % of Float (Sep 30, 2019) 412.48%
Short % of Shares Outstanding (Sep 30, 2019) 410.31%
Shares Short (prior month Aug 30, 2019) 4448.54k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 26/1
Last Split Date 3Jan 25, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-331.99%

Management Effectiveness

Return on Assets (ttm)-158.04%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)4.33M
Revenue Per Share (ttm)0.26
Quarterly Revenue Growth (yoy)-81.20%
Gross Profit (ttm)-1.4M
EBITDA -14.11M
Net Income Avi to Common (ttm)-15.55M
Diluted EPS (ttm)-0.9280
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.29M
Total Cash Per Share (mrq)0.15
Total Debt (mrq)4.58M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.26
Book Value Per Share (mrq)-0.04

Cash Flow Statement

Operating Cash Flow (ttm)-14.03M
Levered Free Cash Flow (ttm)-8.8M